Roche Diagnostics India launches Cobas instrument for SARS CoV-2 testing - (The Economic Times via NewsPoints Desk)

  • Roche Diagnostics India announced the launch of its first cobas 8800 instrument at National Institute of Cholera and Enteric Diseases, Kolkata (ICMR-NICED) and cobas 6800 at National Institute for Research in Reproductive Health, Mumbai (ICMR- NIRRH) to aid with SARS CoV-2 diagnostic testing, as reported The Economic Times on Tuesday.

  • Operating on the real-time reverse transcription polymerase chain reaction platform, SARS-CoV-2 diagnostic tests on the instrument detect the RNA of the virus from nasopharyngeal and oropharyngeal swab samples.

  • Shravan Subramanyam, managing director India and Neighbouring markets of Roche Diagnostics India, said that "the cobas 6800/8800 addresses almost all of the challenges faced by the labs in pandemic times with reduced turnaround time, maintaining testing efficiency and improved productivity of lab personnel on account of automation."

  • The systems provide up to 96 results in about three hours and a total of 384 results for the cobas 6800 system and 960 results for the cobas 8800 system in eight hours.

Did you like this article?